QLT to discontinue trial of punctal plug delivery system for allergic conjunctivitis
Links shared publicly online about this topic.
- 504total visits
QLT to discontinue trial of punctal plug delivery system for allergic conjunctivitis
VANCOUVER, British Columbia — Interim results from a phase 2 proof-of-concept trial have shown that QLT's olopatadine punctal plug delivery
View full resource at osnsupersite.com
Tags: Allergies, Eye Allergy, Eye Infection, Conjunctivitis
Most Recently Shared on February 16, 2011 at 5:15 am By:
QLT to discontinue trial of punctal plug delivery system for #allergic #conjunctivitis: http://ht.ly/3WPe1
Punctal plug delivery system and treatment of allergic conjunctivitis
eyedocnews.com — “Data from trials demonstrated no significant differences between the O-PPDS and placebo-PPDS subjects with respect to reduction in signs and symptoms of allergic conjunctivitis.” View full resource at eyedocnews.com
Most Recently Shared on February 9, 2011 at 6:09 pm By:
Dr. Ari Weitzner Ophthalmologist, Physician, and Doctor
Discuss: QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System: QLT’s O... http://bit.ly/haiAMX
Advertisement
